Otonomy

$3.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+3.27%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Otonomy and other stocks, options, and ETFs commission-free!

About OTIC

Otonomy, Inc. Common Stock, also called Otonomy, is a biopharmaceutical company, which engages in the development of therapeutics for neurotology. Read More The firm's product pipeline includes OTIVIDEX (dexamethasone) Ménière's disease; OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT); OTO-313 (gacyclidine) tinnitus; OTO-413 (BDNF) hidden hearing Loss; OTO-510 (otoprotectant) prevent CIHL; OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan in April 2008 and is headquartered in San Diego, CA. The listed name for OTIC is Otonomy, Inc. Common Stock.

Employees
49
Headquarters
San Diego, California
Founded
2008
Market Cap
182.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
174.94K
High Today
$3.81
Low Today
$3.68
Open Price
$3.68
Volume
91.62K
52 Week High
$4.89
52 Week Low
$1.53

Collections

OTIC Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 5, After Hours

You May Also Like